ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,168Medicare Part D Prescriptions Filled, Including Refills

Rank: 715 out of 6969

$1.05M Total Retail Price of All Prescriptions

Rank: 128 out of 6969

500 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 500 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,862 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

62% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$129 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NEXIUM 292 287 1 52
CRESTOR 224 214 2 39
DIOVAN 191 181 3 26
LOVAZA 189 188 4 77
LIDODERM 177 158 5 75
MELOXICAM 176 166 6 36
PATADAY 174 164 7 213
CELEBREX 172 163 8 67
DEXILANT 165 135 9 110
FORTEO 165 163 9 289
NASONEX 143 137 11 144
EVISTA 130 128 12 118
OMEPRAZOLE 126 123 13 6
AMLODIPINE BESYLATE 124 119 14 4
MUPIROCIN 123 120 15 291
SINGULAIR 122 121 16 84
JANUMET 117 113 17 138
FLUOCINONIDE 117 115 17 134
METOPROLOL SUCCINATE 112 112 19 22
LEVOCETIRIZINE DIHYDROCHLORIDE 112 104 19 335
CREON 111 104 21 147
JANUVIA 110 110 22 41
DONEPEZIL HCL 108 108 23 32
TAMSULOSIN HCL 107 107 24 23
BONIVA 106 106 25 198
CYMBALTA 100 88 26 72
SIMVASTATIN 99 99 27 1
ZOLPIDEM TARTRATE 99 83 27 16
ATORVASTATIN CALCIUM 97 93 29 11
BYSTOLIC 91 91 30 155
ACTONEL 90 90 31 115
EXFORGE 87 87 32 190
DIOVAN HCT 84 76 33 57
IBUPROFEN 82 73 34 29
SPIRIVA 79 79 35 66
TRIBENZOR 77 76 36 359
CLOPIDOGREL 76 76 37 48
SERTRALINE HCL 76 76 37 38
VOLTAREN 75 72 39 105
LEVOFLOXACIN 73 72 40 109
CALCITRIOL 71 71 41 240
TRAMADOL HCL 68 67 42 27
LOSARTAN POTASSIUM 64 63 43 12
DESONIDE 59 56 44 570
NAMENDA 59 59 44 51
GLIMEPIRIDE 55 55 46 44
ISOSORBIDE MONONITRATE ER 53 53 47 81
GABAPENTIN 52 51 48 17
PLAVIX 52 52 48 68
LEVOTHYROXINE SODIUM 51 51 50 5
BENICAR 50 40 51 107
MONTELUKAST SODIUM 50 50 51 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.